National Center for Advancing Translational Sciences; Notice of Closed Meeting, 89463-89464 [2023-28476]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 247 / Wednesday, December 27, 2023 / Notices
Dated: December 20, 2023.
Surekha Vathyam,
Deputy Director, Technology Transfer and
Intellectual Property Office, National Institute
of Allergy and Infectious Diseases.
[FR Doc. 2023–28474 Filed 12–26–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
ddrumheller on DSK120RN23PROD with NOTICES1
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; JCOIN
Methodology Center (MAARC) and JCOIN
Coordination Center (CTC).
Date: February 16, 2024.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Soyoun Cho, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
National Institute on Drug Abuse, NIH, 301
North Stonestreet Avenue, MSC, 6021
Bethesda, MD 20892, (301) 594–9460,
Soyoun.cho@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; NIDA
Research Center of Excellence Grant Program
and NIDA Core ‘‘Center of Excellence’’ Grant
Program.
Date: February 26–27, 2024.
Time: 11:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Soyoun Cho, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
National Institute on Drug Abuse, NIH, 301
North Stonestreet Avenue, MSC, 6021
Bethesda, MD 20892, (301) 594–9460,
Soyoun.cho@nih.gov.
VerDate Sep<11>2014
19:00 Dec 26, 2023
Jkt 262001
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Research at Minority Serving Institutions on
Neurocognitive Mechanisms Underlying the
Impact of Structural Racism on the Substance
Use Trajectory.
Date: March 14, 2024.
Time: 1:30 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Shareen Amina Iqbal,
Ph.D., Scientific Review Officer, Scientific
Review Branch, Division of Extramural
Research, National Institute on Drug Abuse,
NIH, 301 North Stonestreet Avenue, MSC,
6021 Bethesda, MD 20892, (301) 443–4577,
shareen.iqbal@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse and Addiction
Research Programs, National Institutes of
Health, HHS)
Dated: December 21, 2023.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–28574 Filed 12–26–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Advisory Child Health and
Human Development Council Stillbirth
Working Group Meeting
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The Eunice Kennedy Shriver
National Institute of Child Health and
Human Development (NICHD) Stillbirth
Working Group of Council is charged
with identifying current knowledge on
stillbirth and prevention, areas of
improvement for data collection, current
resources for families impacted by
stillbirth, and next steps to gather data
and lower the rate of stillbirth in the
United States.
DATES: The Virtual Meeting will be held
on January 24, 2024, from 9 a.m. to 3:30
p.m. EST.
ADDRESSES: The meeting will be open to
the public. Individuals who need
special assistance, such as sign language
interpretation or other reasonable
accommodations, should notify the
Contact Person listed below in advance
of the meeting. The session will be
Frm 00102
Fmt 4703
videocast and can be accessed from the
NIH Videocasting website (https://
videocast.nih.gov/).
FOR FURTHER INFORMATION CONTACT: For
information concerning this meeting,
Dr. Natasha H. Williams, Branch Chief,
Office of Legislation and Public Policy
NICHD, NIH, 6710B Rockledge Drive,
Bethesda, MD 20892–7510,
natasha.williams2@nih.gov, (240) 551–
4985.
This
notice is pursuant to 42 U.S.C. 285g.
Any interested person may file written
comments with the committee by
forwarding the statement to the Contact
Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.nichd.nih.gov/about/advisory,
where an agenda and any additional
information for the meeting will be
posted when available.
SUPPLEMENTARY INFORMATION:
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS).
Alison N. Cernich,
Deputy Director, Eunice Kennedy Shriver
National Institute of Child Health and Human
Development, National Institutes of Health.
[FR Doc. 2023–28444 Filed 12–26–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
SUMMARY:
PO 00000
89463
Sfmt 4703
National Center for Advancing
Translational Sciences; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
E:\FR\FM\27DEN1.SGM
27DEN1
89464
Federal Register / Vol. 88, No. 247 / Wednesday, December 27, 2023 / Notices
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; CTSA Small Grant Program.
Date: February 13, 2024.
Time: 11:00 a.m. to 1:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Center for Advancing
Translational Sciences, National Institutes of
Health, 6701 Democracy Blvd., Room 1073,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: M. Lourdes Ponce, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Center for Advancing
Translational Sciences, National Institutes of
Health, 6701 Democracy Blvd., Room 1073,
Bethesda, MD 20892, 301–435–0810,
lourdes.ponce@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: December 20, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–28476 Filed 12–26–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF THE INTERIOR
Fish and Wildlife Service
Fish and Wildlife Service,
Interior.
Notice of receipt of permit
applications; request for comments.
ACTION:
We, the U.S. Fish and
Wildlife Service, invite the public to
comment on applications to conduct
certain activities with foreign species
that are listed as endangered under the
Endangered Species Act (ESA). With
some exceptions, the ESA prohibits
activities with listed species unless
Federal authorization is issued that
allows such activities. The ESA also
requires that we invite public comment
before issuing permits for any activity
otherwise prohibited by the ESA with
respect to any endangered species.
DATES: We must receive comments by
January 26, 2024.
ADDRESSES:
Obtaining Documents: The
applications, application supporting
materials, and any comments and other
materials that we receive will be
available for public inspection at
https://www.regulations.gov in Docket
No. FWS–HQ–IA–2023–0253.
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
19:00 Dec 26, 2023
Timothy MacDonald, by phone at 703–
358–2185 or via email at DMAFR@
fws.gov. Individuals in the United States
who are deaf, deafblind, hard of hearing,
or have a speech disability may dial 711
(TTY, TDD, or TeleBraille) to access
telecommunications relay services.
Individuals outside the United States
should use the relay services offered
within their country to make
international calls to the point-ofcontact in the United States.
I. Public Comment Procedures
Foreign Endangered Species; Receipt
of Permit Applications
VerDate Sep<11>2014
FOR FURTHER INFORMATION CONTACT:
SUPPLEMENTARY INFORMATION:
[Docket No. FWS–HQ–IA–2023–0253;
FXIA16710900000–234–FF09A30000]
AGENCY:
Submitting Comments: When
submitting comments, please specify the
name of the applicant and the permit
number at the beginning of your
comment. You may submit comments
by one of the following methods:
• Internet: https://
www.regulations.gov. Search for and
submit comments on Docket No. FWS–
HQ–IA–2023–0253.
• U.S. Mail: Public Comments
Processing, Attn: Docket No. FWS–HQ–
IA–2023–0253; U.S. Fish and Wildlife
Service Headquarters, MS: PRB/3W;
5275 Leesburg Pike; Falls Church, VA
22041–3803.
For more information, see Public
Comment Procedures under
SUPPLEMENTARY INFORMATION.
Jkt 262001
A. How do I comment on submitted
applications?
We invite the public and local, State,
Tribal, and Federal agencies to comment
on these applications. Before issuing
any of the requested permits, we will
take into consideration any information
that we receive during the public
comment period.
You may submit your comments and
materials by one of the methods in
ADDRESSES. We will not consider
comments sent by email or to an address
not in ADDRESSES. We will not consider
or include in our administrative record
comments we receive after the close of
the comment period (see DATES).
When submitting comments, please
specify the name of the applicant and
the permit number at the beginning of
your comment. Provide sufficient
information to allow us to authenticate
any scientific or commercial data you
include. The comments and
recommendations that will be most
useful and likely to influence agency
decisions are: (1) Those supported by
quantitative information or studies; and
(2) those that include citations to, and
analyses of, the applicable laws and
regulations.
PO 00000
Frm 00103
Fmt 4703
Sfmt 4703
B. May I review comments submitted by
others?
You may view and comment on
others’ public comments at https://
www.regulations.gov unless our
allowing so would violate the Privacy
Act (5 U.S.C. 552a) or Freedom of
Information Act (5 U.S.C. 552).
C. Who will see my comments?
If you submit a comment at https://
www.regulations.gov, your entire
comment, including any personal
identifying information, will be posted
on the website. If you submit a
hardcopy comment that includes
personal identifying information, such
as your address, phone number, or
email address, you may request at the
top of your document that we withhold
this information from public review.
However, we cannot guarantee that we
will be able to do so. Moreover, all
submissions from organizations or
businesses, and from individuals
identifying themselves as
representatives or officials of
organizations or businesses, will be
made available for public disclosure in
their entirety.
II. Background
To help us carry out our conservation
responsibilities for affected species, and
in consideration of section 10(c) of the
Endangered Species Act of 1973, as
amended (ESA; 16 U.S.C. 1531 et seq.),
we invite public comments on permit
applications before final action is taken.
With some exceptions, the ESA
prohibits certain activities with listed
species unless Federal authorization is
issued that allows such activities.
Permits issued under section 10(a)(1)(A)
of the ESA allow otherwise prohibited
activities for scientific purposes or to
enhance the propagation or survival of
the affected species. Service regulations
regarding prohibited activities with
endangered species, captive-bred
wildlife registrations, and permits for
any activity otherwise prohibited by the
ESA with respect to any endangered
species are available in title 50 of the
Code of Federal Regulations in part 17.
III. Permit Applications
We invite comments on the following
applications.
Applicant: San Diego Zoo Wildlife
Alliance, San Diego, CA; Permit No.
PER5681188.
The applicant requests a permit to
import one wild Fiji crested iguana
(Brachylophus vitiensis) and five wild
Fiji banded iguanas (Brachylophus
fasciatus) from Spain for the purpose of
enhancing the propagation or survival of
E:\FR\FM\27DEN1.SGM
27DEN1
]]>Agencies
[Federal Register Volume 88, Number 247 (Wednesday, December 27, 2023)]
[Notices]
[Pages 89463-89464]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-28476]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Advancing Translational Sciences; Notice of
Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
[[Page 89464]]
Name of Committee: National Center for Advancing Translational
Sciences Special Emphasis Panel; CTSA Small Grant Program.
Date: February 13, 2024.
Time: 11:00 a.m. to 1:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Center for Advancing Translational Sciences,
National Institutes of Health, 6701 Democracy Blvd., Room 1073,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: M. Lourdes Ponce, Ph.D., Scientific Review
Officer, Office of Scientific Review, National Center for Advancing
Translational Sciences, National Institutes of Health, 6701
Democracy Blvd., Room 1073, Bethesda, MD 20892, 301-435-0810,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.859,
Pharmacology, Physiology, and Biological Chemistry Research; 93.350,
B--Cooperative Agreements; 93.859, Biomedical Research and Research
Training, National Institutes of Health, HHS)
Dated: December 20, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-28476 Filed 12-26-23; 8:45 am]
BILLING CODE 4140-01-P
